Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levorag Emulgel vs Diltiazem for Chronic Anal Fissure
NCT02158013Terminated
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Sep 2014
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Randomised, open-label trial of Levorag Emulgel in chronic anal fissure (CAF), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Complete healing at week 12. Started Sep 2014; status: terminated.
02
Drugs
Levorag Emulgel
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on NCT02158013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02158013.